China's First Actinium-225 Mass Production Qualification Lands in Chongqing: SPIC Isotope Synergy Accelerates Breakthrough in High-End Medical Isotope Supply Chain Bottleneck
The Ministry of Ecology and Environment recently officially issued a Class A unsealed radioactive material radiation safety license to SPIC Isotope Synergy (Chongqing) Technology Co., Ltd. The issuance of this administrative license marks that the company has officially become the first enterprise in China with full-chain legal qualifications for the mass production, sales, and use of the medical isotope Actinium-225 (Ac-225), filling the gap in China's large-scale supply of novel targeted radionuclides. SPIC Isotope Synergy is located in Bafu Town, Chongqing High-tech Zone, and has been selected for the 2026 Chongqing Potential Unicorn Enterprise Cultivation List. The first phase of the project has a total investment of 918 million RMB, with core technical equipment relying on self-built 120 MeV and 50 MeV high-power medical proton cyclotrons.
2026-10-15
